Evaluating Trichophyton tonsurans Carriage and Infection

评估断发毛癣菌的携带和感染

基本信息

项目摘要

DESCRIPTION (provided by the applicant): Tinea capitis is an overwhelmingly prevalent disease in the pediatric population being estimated to occur in approximately 1 in 20 children. Moreover, an equal and often larger number of children serve as asymptomatic carriers of the pathogen. Of particular interest is that a single species of fungus, namely Trichophyton tonsurans, is responsible for both clinical presentations. With other infectious agents, unique serotypes have been clearly associated with pathogenicity and virulence (e.g., E. coli. M. meningitides, H. influenzae); however, there has been no attempt to identify and link genotypic variants of T. tonsurans with clinical disease status. Recognizing that variants exist and linking specific subtypes to disease presentation is the first step toward identifying distinct molecular targets that may guide the development of therapeutic interventions designed to slow or halt disease transmission and progression. The proposed investigation will employ a targeted molecular analysis in tandem with cross sectional sampling and longitudinal surveillance in a population of normal healthy children to explore the carrier and infection states of T. tonsurans. The investigation will be driven by the general hypotheses: the type of genotypic variant to which a child is exposed accounts for the presentation status observed in Trichophyton tonsurans infection. The hypothesis will be tested by a series of studies designed to address the following specific aims: (1) determine the genotype distribution of T. tonsurans isolates acquired from a fixed population of "high-risk" children and evaluate whether variations in genotype are responsible for differences in disease presentation, specifically infection vs. carriage, between individuals and (2) characterize the degree of relatedness for sequential isolates within an individual and identify whether transformation between disease presentations occurs with the same genetic variant or as a result of acquiring a genetically distinct fungal variant.
描述(由申请方提供):头癣是儿科人群中的一种非常普遍的疾病,估计约1/20的儿童发生。此外,同样数量且往往更多的儿童是该病原体的无症状携带者。特别令人感兴趣的是,一种真菌,即断毛癣菌,是负责这两种临床表现。对于其他感染因子,独特的血清型已明确与致病性和毒力相关(例如,E.杆菌M. meningitides、H.流感);然而,还没有尝试鉴定和链接T.有临床疾病状态的扁桃体炎患者。认识到变异的存在并将特定亚型与疾病表现联系起来是确定不同分子靶点的第一步,这些靶点可能会指导旨在减缓或阻止疾病传播和进展的治疗干预措施的开发。本研究将采用有针对性的分子分析,结合横断面抽样和纵向监测,在健康儿童人群中探索T. Tonsurans。调查将由一般假设驱动:儿童暴露的基因型变异类型解释了断尾毛癣菌感染中观察到的表现状态。本研究将通过一系列研究来验证这一假设,这些研究旨在解决以下具体目标:(1)确定T。从“高危”儿童的固定人群中获得的tonsurans分离物,并评估基因型的变化是否是疾病表现差异的原因,特别是感染与携带,人与人之间(2)表征个体内连续分离株的相关性程度,并确定疾病表现之间的转化是否发生在相同的遗传变异中,或者是由于获得了遗传上不同的真菌变种

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUSAN M ABDEL-RAHMAN其他文献

SUSAN M ABDEL-RAHMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUSAN M ABDEL-RAHMAN', 18)}}的其他基金

Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology
儿童慈善医院儿科药理学合作奖学金计划
  • 批准号:
    9270585
  • 财政年份:
    2011
  • 资助金额:
    $ 15.73万
  • 项目类别:
Ensuring Medication Safety in Pediatric Emergencies
确保儿科紧急情况下的用药安全
  • 批准号:
    8300431
  • 财政年份:
    2011
  • 资助金额:
    $ 15.73万
  • 项目类别:
Low Cost Monitoring Strategy to Optimize Tuberculosis Treatment in Children
优化儿童结核病治疗的低成本监测策略
  • 批准号:
    8293006
  • 财政年份:
    2011
  • 资助金额:
    $ 15.73万
  • 项目类别:
Low Cost Monitoring Strategy to Optimize Tuberculosis Treatment in Children
优化儿童结核病治疗的低成本监测策略
  • 批准号:
    8133638
  • 财政年份:
    2011
  • 资助金额:
    $ 15.73万
  • 项目类别:
Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology
儿童慈善医院儿科药理学合作奖学金计划
  • 批准号:
    9114327
  • 财政年份:
    2011
  • 资助金额:
    $ 15.73万
  • 项目类别:
Childrens Mercy Hospital Fellowship Program in Pediatric Pharmacology
儿童慈善医院儿科药理学奖学金计划
  • 批准号:
    8852151
  • 财政年份:
    2011
  • 资助金额:
    $ 15.73万
  • 项目类别:
Evaluating Trichophyton tonsurans Carriage and Infection
评估断发毛癣菌的携带和感染
  • 批准号:
    7140196
  • 财政年份:
    2005
  • 资助金额:
    $ 15.73万
  • 项目类别:
FUNGAL PROTEIN/GLYCOPROTEIN EXPRESSION IN TINEA CAPITIS
头癣中真菌蛋白/糖蛋白的表达
  • 批准号:
    6512243
  • 财政年份:
    2001
  • 资助金额:
    $ 15.73万
  • 项目类别:
FUNGAL PROTEIN/GLYCOPROTEIN EXPRESSION IN TINEA CAPITIS
头癣中真菌蛋白/糖蛋白的表达
  • 批准号:
    6259345
  • 财政年份:
    2001
  • 资助金额:
    $ 15.73万
  • 项目类别:
FUNGAL PROTEIN/GLYCOPROTEIN EXPRESSION IN TINEA CAPITIS
头癣中真菌蛋白/糖蛋白的表达
  • 批准号:
    6632804
  • 财政年份:
    2001
  • 资助金额:
    $ 15.73万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.73万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 15.73万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 15.73万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 15.73万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 15.73万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 15.73万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 15.73万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 15.73万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 15.73万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 15.73万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了